Corporate
CovalX Services CovalX AG was founded in 2006
CovalX’s vision is to become a leading provider of analytical services, based on advanced mass spectrometry. With headquarters in Zurich, Switzerland, support offices and laboratories in Switzerland, France and the United States, CovalX operates as a global organization delivering high-quality biotherapeutic analytical services to major pharmaceutical and biotechnology companies worldwide.
Our specialized mass spectrometry-based solutions support epitope mapping, de novo sequencing and mAb Characterization, including critical stages of drug discovery and development. Through our strategically located offices and strong international collaboration network, we ensure seamless project execution and scientific support across Europe and United States.
CovalX is committed to delivering reliable, high-resolution data and actionable insights that help accelerate decision-making and reduce risk in biotherapeutic development research programs.
To learn more about our capabilities or discuss your project needs, please contact us at info@covalx.com or Contact Us form.